Statement from Chief Public Health Officer of Canada on April 14, 2021

From: Public Health Agency of Canada
On April 14, 2021, Dr. Theresa Tam, Canada’s Chief Public Health Officer, issued the following statement on COVID-19.
April 14, 2021 Ottawa, ON Public Health Agency of Canada
The COVID-19 pandemic continues to create stress and anxiety for many Canadians, particularly those who do not have ready access to their regular support networks. Through the Wellness Together Canada online portal, people of all ages across the country can access immediate, free and confidential mental health and substance use supports, 24 hours a day, seven days a week.
The Public Health Agency of Canada (PHAC) has received a report of a case of an individual in Canada who has experienced a very rare but serious medical event involving blood clots (thrombosis) with low levels of blood platelets (thrombocytopenia), following immunization with COVISHIELD (the Serum Institute of India version of the AstraZeneca COVID-19 vaccine). This is the first reported case of this rare adverse event in Canada. Global evidence indicates that reports of blood clots with low platelets in people following immunization with the AstraZeneca COVID-19 vaccine are very rare.

Related Keywords

Canada ,India ,Ottawa ,Ontario ,Canadians ,Canadian ,Theresa Tam ,Public Health ,Astrazeneca ,National Advisory Committee On Immunization ,Public Health Agency Of Canada ,Officers Of Health ,Health Canada ,Serum Institute Of India ,Chief Public Health Officer ,Health Agency ,Public Health Agency ,Serum Institute ,National Advisory Committee ,Chief Medical Officers ,கனடா ,இந்தியா ,ஆடவா ,ஆஂடேரியொ ,கனடியர்கள் ,கனடியன் ,தெரேசா டாம் ,பொது ஆரோக்கியம் ,அதிகாரிகள் ஆஃப் ஆரோக்கியம் ,ஆரோக்கியம் கனடா ,சீரம் நிறுவனம் ஆஃப் இந்தியா ,தலைமை பொது ஆரோக்கியம் அதிகாரி ,சீரம் நிறுவனம் ,தலைமை மருத்துவ அதிகாரிகள் ,